Securities Registration: Employee Benefit Plan (s-8)
May 15 2023 - 4:37PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission
on May 15, 2023
Registration No. 333-
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Bioceres
Crop Solutions Corp.
(Exact name of registrant as specified in its charter)
The Cayman Islands
(State or other jurisdiction of
incorporation or organization) |
N/A
(I.R.S. Employer
Identification No.) |
Ocampo 210 bis, Predio CCT, Rosario
Province of Santa Fe, Argentina
(Address of principal executive offices) (Zip code)
2023 Omnibus Equity Incentive Plan
(Full title of the plan)
Cogency Global Inc.
122 East 42nd Street, 18th Floor
New York, NY 10168
(212) 947-7200
(Name and address of agent for service) (Telephone
number, including area code, of agent for service)
Copies
to:
Matthew
S. Poulter, Esq.
Andrew Gaines, Esq.
Pierre-Emmanuel
Perais, Esq.
Linklaters LLP
1290 Avenue of the Americas
New York, NY 10104
Phone: (212) 903-9000
Fax: (212) 903-9100 |
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
¨ |
|
Accelerate
filer |
x |
Non-accelerated
filer |
¨ |
|
Smaller reporting company |
¨ |
Emerging growth company |
x |
|
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
EXPLANATORY
NOTE
Registration of Additional
Ordinary Shares. This registration statement on Form S-8 is being filed by Bioceres Crop Solutions Corp. (the “Registrant”,
the “Company”, “BIOX” or “we”) for the purpose of registering 1.7 million ordinary shares of the
Company, par value $0.0001 per share (the “Ordinary Shares”), initially issuable under the 2023 Omnibus Equity Incentive
Plan (the “2023 Plan”).
On May 12, 2023, the
board of directors of the Company approved the 2023 Omnibus Equity Incentive Plan, which amends and restates in its entirety (i) the
Employee Stock Purchase Plan, (ii) the Equity Compensation Plan, (iii) the Employee Stock Option Plan, (iv) the Stand Alone
Stock Option Grant to Kyle Bransfield, (v) the Stand Alone Stock Option Grant to Carlos Ivan Camargo de Colon, (vi) the Stand
Alone Stock Option Grant to Gloria Montaron Estrada, (vii) the Stand Alone Stock Option Grant to Ari Freisinger, (viii) the
Stand Alone Stock Option Grant to Enrique Lopez Lecube, (ix) the Stand Alone Stock Option Grant to Federico Trucco, (x) the
Stand Alone Stock Option Grant to Jorge Wagner, (xi) the Stand Alone Stock Option Grant to Geronimo Watson, and (xii) the Stand
Alone Stock Option Grant to Natalia Zang.
Incorporation
by Reference. This Registration Statement is filed pursuant to General Instruction E to Form S-8. The contents of the
Registration Statements on Form
S-8 (File No. 333-255635) are incorporated herein by reference and made a part hereof.
PART II
INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT
Item 3. | Incorporation of Documents By Reference. |
This registration statement
incorporates important business and financial information about that is not included in or delivered with the registration statement.
The Commission allows us to “incorporate by reference” information filed with the Commission, which means that we can disclose
important information to you by referring you to those documents. The information incorporated by reference is considered to be part of
this registration statement, and certain later information that we file with the Commission will automatically update and supersede this
information.
This document incorporates
by reference the following documents that have previously been filed with the Commission by us:
This
document incorporates by reference the following documents that have previously been filed with the Commission by Pro Farm Group, Inc.
(formerly Marrone Bio Innovations, Inc.) (“Pro Farm”):
All other reports and documents
subsequently filed (but not furnished) by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the
date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates
that all securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be
incorporated by reference herein and to be a part hereof from the date of filing of such reports and documents.
Any statement contained in
this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein shall
be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or
in any subsequently filed amendment to this Registration Statement or in any document that also is or is deemed to be incorporated by
reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this Registration Statement.
Under no circumstances shall
any information subsequently furnished on Form 6-K be deemed incorporated herein by reference unless such Form 6-K expressly
provides to the contrary.
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the Rosario, Argentina, on this 15 day of May, 2023.
| Bioceres Crop Solutions Corp. |
| |
| By: |
/s/ Federico
Trucco |
| |
Name: Federico
Trucco |
| |
Title: Chief
Executive Officer and Executive Director |
POWER OF ATTORNEY
We, the undersigned directors
and officers of Bioceres Crop Solutions Corp., hereby severally constitute and appoint Federico Trucco and Gloria Montaron Estrada each
of them singly, his/her true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution for him/her
and in his/her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments)
to this registration statement, and any subsequent registration statements pursuant to Rule 462 of the United States Securities Act
of 1933, as amended, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities
and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform
each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he
might or could do in person, hereby ratifying and confirming all that each of said attorney-in-fact or his/her substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and
on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ Federico Trucco
| |
|
|
May 15, 2023 |
Federico Trucco |
|
Chief Executive Officer and Executive Director |
|
|
|
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/ Enrique Lopez Lecube
| |
|
|
May 15, 2023 |
Enrique Lopez Lecube |
|
Chief Financial Officer and Executive Director |
|
|
|
|
(Principal Financial Officer) |
|
|
|
|
|
|
|
/s/ Gloria Montaron Estrada
| |
|
|
May 15, 2023 |
Gloria Montaron Estrada |
|
Non-Executive Director |
|
|
|
|
|
|
|
/s/ Natalia Zang
| |
|
|
May 15, 2023 |
Natalia Zang |
|
Non-Executive Director |
|
|
|
|
|
|
|
/s/ Ari Freisinger
| |
|
|
May 15, 2023 |
Ari Freisinger |
|
Non-Executive Director |
|
|
|
|
|
|
|
/s/ Keith McGovern
| |
|
|
May 15, 2023 |
Keith McGovern |
|
Non-Executive Director |
|
|
|
|
|
|
|
/s/ Yogesh Mago
| |
|
|
May 15, 2023 |
Yogesh Mago |
|
Non-Executive Director |
|
|
SIGNATURE
OF AUTHORIZED U.S. REPRESENTATIVE
Pursuant
to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Bioceres Crop
Solutions Corp., has signed this registration statement on this 15 day of May, 2023.
|
COGENCY GLOBAL INC. |
|
|
|
|
By: |
/s/ Colleen A. De Vries |
|
|
Name: Colleen A. De Vries |
|
|
Title: Senior Vice President on behalf of Cogency Global Inc. |
Bioceres Crop Solutions (NASDAQ:BIOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioceres Crop Solutions (NASDAQ:BIOX)
Historical Stock Chart
From Jul 2023 to Jul 2024